T
Tori Hudson
Author
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
OCT 5
Aug 18, 2026
Testosterone Dosing in Menopause: Protocols, Pitfalls & the Evidence Gap
4:52
5:15
5:28
5:46
J
4:48Jaclyn SmeatonHOST
... can you talk a little bit about how things have shifted in your practice?

Tori HudsonGUEST
Well, I mean, I mean, a- as you kind of inferred, there's sort of been, there seems like there's sort of three eras of hormone prescribing for peri- and post-menopausal women.

Tori HudsonGUEST
And the primary reason for prescribing was to reduce the risk of cardiovascular disease, and that was the primary indication.

Tori HudsonGUEST
And of course, that wasn't all that compelling at the time to me, because w- I felt like natural medicine does a very excellent job at reducing the risk of cardiovascular disease.

Tori HudsonGUEST
So it was sort of, yes, it was recommended robustly, routinely, and then 2002, you know, kind of the, that world fell apart, and oh, my God, we're ... causing harm and therefore we shouldn't be prescribing it at all was sort of the vibe, um, because it's gonna cause this, this, that, and that.
10 MINS LATER